Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Georges Gemayel
Age : 60
Public asset : 563,512 USD
Linked companies : Supernus Pharmaceuticals, Inc. - Gemini Therapeutics, Inc. - Orphazyme A/S
Summary 
Georges Gemayel is an American businessperson who has been at the helm of 11 different companies. Currently, Dr. Gemayel holds the position of Chairman at OxThera AB, Chairman of Enterome SA, Chairman at Orphazyme A, Chairman for Dynacure SA and Executive Chairman of Gemini Therapeutics, Inc. Georges Gemayel is also on the board of Supernus Pharmaceuticals, Inc., International Institute of New England, Gemayel Family Foundation and St Andrews School In Ngong, Inc. and Partner at Gemayel Investment LLC.

In his past career Dr. Gemayel occupied the position of Chairman, President & Chief Executive Officer of Altus Pharmaceuticals, Inc., Executive Chairman at Syndexa Pharmaceuticals Corp., Executive Chairman at Syndex Corp., Executive Chairman of Vascular Magnetics, Inc., Vice President-National Specialty Care at Roche Corp., Executive Chairman for FoldRx Pharmaceuticals, Inc., Chairman at EpiTherapeutics ApS, Executive Vice President-Therapeutics at Genzyme Corp., Vice President-National Specialty Care at Hoffmann-La Roche, Inc., General Manager of Hoffmann-La Roche Portugal and General Manager at Roche Farmacêutica Química Lda.

He received a doctorate from St. Joseph University and a doctorate and a graduate degree from Université de Paris XI Paris Sud.


Current positions of Georges Gemayel 
NameTitle Since
Supernus Pharmaceuticals, Inc.
(Pharmaceuticals)
Independent Director 2015
Gemini Therapeutics, Inc.
(Biotechnology & Medical Research)
Executive Chairman 2021
Orphazyme A/S
(Biotechnology & Medical Research)
Chairman 2014
OxThera AB Chairman 2014
Dynacure SA Chairman 2018
Enterome SA Chairman 2015
International Institute of New England Director -
Gemayel Family Foundation Trustee -
St Andrews School In Ngong, Inc. Director -
Gemayel Investment LLC Partner 2012


Holdings of Georges Gemayel 
NameEquities%Valuation
Orphazyme A/S (ORPHA)
(Biotechnology & Medical Research)
100,8090.29%424,535 USD
Supernus Pharmaceuticals, Inc. (SUPN)
(Pharmaceuticals)
5,2110.0098%138,977 USD
Gemini Therapeutics, Inc. (GMTX)
(Biotechnology & Medical Research)
00.0000%0 USD


Georges Gemayel: Personal Network 
Most Read News 
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
RE
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/20JACK MA : Alibaba founder Ma spotted in Mallorca in rare trip abroad after China scrutiny
RE
10/22WARREN BUFFETT : Generali closer to controlling Cattolica after Buffett tenders shares - source
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/21ALEXANDRE RICARD : Pernod Ricard 1Q Sales Soar as Drinkers Head to the Bars
DJ
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/25ELON MUSK : WRAPUP 3-Tesla zooms past $1 trillion market cap on bet that the EV future is now
RE
10/20ELON MUSK : No Elon Musk Show during this Tesla quarterly call
RE
More news


© 2021 People and Ownership :   
Georges Gemayel : Connections